Etiologic treatment of hepatitis C virus-associated mixed cryoglobulinemia

Digestive and Liver Disease

Volumn 39, Issue SUPPL. 1, 2007, Pages

  Mazzaro, Cesare ^a   Pozzato, Gabriele ^b   Zorat, Francesca ^b   Baragiotta, Anna Maria ^c   Biscontin, Maria Grazia ^a   Spina, Michele ^d   Tirelli, Umberto ^d  

^a Department of Internal Medicine

^b UNIVERSITY OF TRIESTE   (Italy)

^c Division of Gastroenterology

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Hepatitis C virus; Mixed cryoglobulinemia; Peginterferon

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; AMINOTRANSFERASE; ANTIVIRUS AGENT; COLCHICINE; CORTICOSTEROID; CRYOGLOBULIN; CYCLOSPORIN; INTERFERON; PEGINTERFERON; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2B; RIBAVIRIN; STEROID; UNCLASSIFIED DRUG;

ANEMIA; ARTHRALGIA; ARTICLE; AUTOIMMUNE THYROIDITIS; BIOCHEMISTRY; BONE MARROW TOXICITY; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CRYOGLOBULINEMIA; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; LEUKOPENIA; MONOTHERAPY; NONHUMAN; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PURPURA; RELAPSE; THROMBOCYTOPENIA; VIROLOGY; VIRUS INHIBITION; VIRUS REPLICATION;

CRYOGLOBULINEMIA; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON-ALPHA; POLYETHYLENE GLYCOLS; RIBAVIRIN;

EID: 35148898142     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(07)80020-X     Document Type: Article

References (38)

1. Agnello V., Chung R., and Kaplan L. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327 (1992) 1490-1495
2. Ferri C., Greco E Longobardo G., Palla R Moretti A., Matzo E., et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 9 (1991) 621-624
3. Pozzato G., Mazzaro C., Crovatto M., Modolo M., Ceselli S., Mazzi G., et al. Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. Blood 84 9 (1994) 3047-3053
4. Mazzaro C., Zagonel V., Monfardini S., Tulissi R Pussini E., Fanni- Canelles M., et al. Hepatitis C virus and non-Hodgldn's lymphomas. Br J Haematol 92 (1996) 1275-1279
5. Silvestri E., Pipan C., Barillari G., Zaja E., Fanin R., Infanti L., et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87 10 (1996) 4296-4301 May 15
6. Vacca A., and Dammacco E. Deflazacort versus prednisone in the treatment of EMC: a controlled clinical study. Int Arch Allergy Appl Immunol 99 (1992) 306-313
7. Ballar M., Bobbio E., Poggi S., Bordin G., Bertoncelli M., Catania E., et al. A pilot study on the effectiveness of cyclosporine in type II mixed cryoglobulinemia. Clin Exp Rheumatol 13 Suppl 13 (1995) S201-S203
8. Monti G., Saccardo E., Rinaldi G., Petrozzino M., Gomitoni A., and Invernizzi E. Colchicine in the treatment of mixed cryoglobulinemia. Clin Exp Rheumatol 13 Suppl 13 (1995) S197-S199
9. Ferri C., Gremignani G., Bombardieri S., Moriconi L., Pontrandolfo A., Vitali C., et al. Plasma exchange in mixed cryoglobulinemia: the effect on renal, liver and neurologic involvement. Ric Clin Lab 16 2 (1986) 403-411
10. Tavoni A., Mosca M., Ferri C., Moriconi L., La Civita L., and Lombardini E. Guidelines for the management of essential mixed cryoglobulinemia. ClinExpRheumatol 13 Suppl 13 (1995) S191-S195
11. Willson R. The benefit of long-term interferon alfa therapy for symptomatic mixed cryoglobulinemia (cutaneous vasculitis/ membranoproliferative glomerulonephritis) associated with chronic hepatitis C. J Clin Gastroenterol 33 2 (2001) 137-140
12. De Rosa F., Di Lullo L., Coviello R., Donanno S., Laganfl B., and Casato M. Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia [letter]. J Hepatol 28 2 (1998) 335
13. Mazzaro C., Lacchin T., Moretti M., Tulissi R Manazzone O., Colle R., et al. Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia. Clin Exp Rheumatol 13 Suppl 13 (1995) S181-S185
14. Mazzaro C., Carniello G., Doretto R Mazzi G., Crovatto M., and Santini G. Interferon therapy in HCV-positive mixed cryoglobulinemia: viral and host factors contributing to efficacy of the therapy. It J Gastroenterol Hepatol 29 (1997) 343-347
15. Zuckerman E., Keren D., Slobodin G., Rozenbaum M., Toubi E., Sabo E., et al. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 27 (2000) 2172-2178
16. Bonomo L., Casato M., Afedra A., and Caccavo D. Treatment of idiopatic mixed cryoglobulinemia with alfa-interferon. Am J Med 83 (1987) 726-731
17. Casato M., Laganfl B., Antonelli G., and Dianzani E Bonomo L. Long- term results of therapy with interferon alfa for type II mixed cryoglobulinemia: a long term, randomized, controlled study. Blood 84 (1991) 3336-3343
18. Ferri C., Matzo E., Longobardo G., Lombardini E La Civita L., Vanacore R., et al. Alpha interferon in mixed cryoglobulinemia patients: a randomized crossover controlled trial. Blood 81 (1993) 1132-1136
19. Misiani R., Belavita R Fenili D., Vicari A., Marchesi D., Sironi P., et al. Interferon C~-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330 (1994) 751-756
20. Dammacco E Sansonno D., Hart J., Shymala V., Cornacchiulo V., Iacobelli A., et al. Natural interferon alpha versus its combination with 6-methyl prednisolone in the therapy of type II mixed cryoglobulinemia: a long term, randomized crossover controlled trial. Blood 84 (1994) 3336-3343
21. Mazzaro C., Pozzato G., Crivatto M., Moretti M., Modolo M., Mazzi G., et al. Long-term effects of alpha interferon therapy and disappearance of cryoglobulinemia in patients with hepatitis C virus. Haematologica 79 (1994) 342-349
22. Mazzaro C., Franzin E Tulissi R Passini E., Crovatto M., Carniello G., et al. Regression of monoclonal B-cell expansion patients affected by mixed cryoglobulinemia responsive to c~ interferon therapy. Cancer 77 (1996) 2604-2613
23. Pioltelli R., Maldifassi R., Vacca A., Mazzaro C., Mussini C., Migliaresi S., et al. GISC protocol experience in the treatment of essential mixed cryoglobulinemia. Clin Exp Rheumatol 13 Suppl 13 (1995) S187-S190
24. Casato M., Agnello V., Pupillo LR Knight G., Leoni M., del Vecchio S., et al. Predictor of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90 (1997) 3865-3873
25. Mazzaro C., Carniello G., Doretto R Mazzi G., Crovatto M., and Santini G. Interferon therapy in HCV-positive mixed cryoglobulinemia: viral and host factors contributing to efficacy of the therapy. It J Gastroenterol Hepatol 29 (1997) 343-347
26. Ferri C., Zignego A., and Pileri S. Cryoglobulins [review]. J Clin Pathol 55 (2002) 4-13
27. Lidove O., Cacoub R Hausfater R Wechsler B., Frances C., Leger J., et al. Cryoglobulinemia and hepatitis C: worsening of peripheral neuropathy after interferon alpha treatment. Gastroenterol Clin Biol 23 (1999) 403-406
28. Mazzaro C., Colle R., Baracetti S., and Nascimben E Zorat E Pozzato G. Effectiveness of leukocyte interferon in patients affected by HCV- positive mixed cryoglobulinemia resistant to recombinant alpha- interferon. Clin Exp Rheumatol 20 (2002) 17-24
29. Calleja J., Albillos A., Moreno-Otero R., Rossi I., Cacho G., and Domper E. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinemia. Aliment Pharmacol Ther 13 9 (1999) 1179-1186
30. Cacoub R Lidove O., Laisonobe T., Duhaut R Thibault V., and Ghillani R. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Artritis Rheum 46 (2002) 3317-3326
31. Mazzaro C., Zorat E Comar C., Nascimben E Bianchini D., Baracetti S., et al. Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia. J Rheumatol 30 (2003) 1775-1781
32. Cacoub R., Saadoun D., Limal N., Sene D., Lidove I., Piette, et al. Pegylated interferon alfa 2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 52 (2005) 911-915
33. Mazzaro C., Zorat E., Caizzi M., Donada C., Di Gennaro G., Maso L., et al. Treatment with peg-interferon alfa 2-b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 42 (2005) 632-638
34. Donada C., Crucitti A., Donadon V., Chemello L., and Alberti A. Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Blood 92 (1998) 2983-2984
35. Zaja E De Vita S., Mazzaro C., Sacco S., Damiani D., De Marchi G., et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101 (2003) 3827-3834
36. Sansonno D., De Re V., Lauletta G., Tucci AE Boiocchi M., and Dammacco E. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon a with an anti-CD20. Blood 101 (2003) 3818-3826
37. Devis G., Esteban-Mur E., Rustgi V., Hoefs L., Gordon S., Trepo C., et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 339 (1988) 1493-1499
38. Perry C., and Jarvis B. Peginterferon-alpha-2a (40kD): a review of its use in the management of chronic hepatitis C. Drugs 61 (2001) 2263-2288